Carisma Therapeutics Inc
NASDAQ:CARM
Carisma Therapeutics Inc
NASDAQ:CARM
Price:
0.032
USD
-4.76%
Market Closed
Market Cap:
$1.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Carisma Therapeutics Inc
NASDAQ:CARM
|
US |
|
Brookfield Infrastructure Corp
NYSE:BIPC
|
US |
|
Helen of Troy Ltd
NASDAQ:HELE
|
BM |
|
China Huarong Asset Management Co Ltd
HKEX:2799
|
CN |
|
VIP Play Inc
OTC:VIPZ
|
US |
|
Garo AB
STO:GARO
|
SE |
|
Al Rajhi Company for Cooperative Insurance SJSC
SAU:8230
|
SA |
|
Gen Digital Inc
NASDAQ:GEN
|
US |
|
Multi Indocitra Tbk PT
IDX:MICE
|
ID |
|
Goodbaby International Holdings Ltd
HKEX:1086
|
CN |
|
A
|
Aju IB Investment Co Ltd
KOSDAQ:027360
|
KR |
|
Angold Resources Ltd
XTSX:AAU
|
CA |
|
Clairvest Group Inc
TSX:CVG
|
CA |
|
J
|
Jiangsu Leadmicro Nano Technology Co Ltd
SSE:688147
|
CN |
|
Foxtron Vehicle Technologies Co Ltd
TWSE:2258
|
TW |
|
AdEPT Technology Group PLC
LSE:ADT
|
UK |
|
S
|
SPAR Group Inc
XBER:PMH
|
US |
|
M
|
MKB Nedsense NV
SWB:BFE
|
NL |
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
IL |
|
S
|
Shandong Hi-Speed Holdings Group Ltd
F:HRI
|
HK |
|
G
|
Global Strategic Group Ltd
HKEX:8007
|
HK |
|
Probiotec Ltd
ASX:PBP
|
AU |
|
Novo Resources Corp
TSX:NVO
|
CA |
|
I
|
Inter Industries Plus Ltd
TASE:ININ
|
IL |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CARM.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CARM
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
CARM Competitors Multiples
Carisma Therapeutics Inc Competitors
Carisma Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Carisma Therapeutics Inc
NASDAQ:CARM
|
1.3m USD | 0.1 | -0 | 0 | 0 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.7 | 37.5 | 40.9 | 41.7 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
